Table: Ono Pharm -2024/25 group forecast(IFRS)
Apr 28 (Reuters) -
Ono Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2025 Mar 31, 2025
LATEST PREVIOUS
FORECAST FORECAST
Sales 487.00 485.00
Operating 60.00 82.00
PreTax 60.00 81.50
Net 50.00 58.00
EPS Basic 106.46 yen 123.49 yen
NOTE - Ono Pharmaceutical Co Ltd.(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours